Immunological profiling as a means to invigorate personalized cancer therapy

Por Hegmans, Joost PJJ, Aerts, Joachim GJV
Publicado em 2013

Biomarkers in malignant mesothelioma—an unfulfilled need or a waste of resources?

Por Cornelissen, Robin, Aerts, Joachim G.J.V.
Publicado no J Thorac Dis (2018)

Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma

Por Minnema-Luiting, Jorien, Vroman, Heleen, Aerts, Joachim, Cornelissen, Robin
Publicado no Int J Mol Sci (2018)

Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment

Por Belderbos, Robert A., Aerts, Joachim G.J.V., Vroman, Heleen
Publicado no Mol Ther Oncolytics (2019)

Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma

Por Belderbos, Robert A., Vroman, Heleen, Aerts, Joachim G. J. V.
Publicado no Front Oncol (2020)

A Patient with Four-Year Survival after Nonsmall Cell Lung Carcinoma with a Solitary Metachronous Small Bowel Metastasis

Por Kant, Klaas M., Noordhoek Hegt, Vincent, Aerts, Joachim G. J. V.
Publicado em 2010

Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?

Por Huber, Anne, Dammeijer, Floris, Aerts, Joachim G. J. V., Vroman, Heleen
Publicado no Front Immunol (2018)

Improving lung cancer survival; time to move on

Por Heuvers, Marlies E, Hegmans, Joost P, Stricker, Bruno H, Aerts, Joachim G
Publicado em 2012

Immunotherapy prospects in the treatment of lung cancer and mesothelioma

Por Aerts, Joachim G., Lievense, Lysanne A., Hoogsteden, Henk C., Hegmans, Joost P.
Publicado no Transl Lung Cancer Res (2014)

Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy

Por van Gulijk, Mandy, Dammeijer, Floris, Aerts, Joachim G. J. V., Vroman, Heleen
Publicado no Front Immunol (2018)

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?

Por Cantini, Luca, Hassan, Raffit, Sterman, Daniel H., Aerts, Joachim G. J. V.
Publicado no Front Oncol (2020)

The distress thermometer as a predictor for survival in stage III lung cancer patients treated with chemotherapy

Por de Mol, Mark, den Oudsten, Brenda L., Aarts, Mieke, Aerts, Joachim G.J.V.
Publicado no Oncotarget (2016)

Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment

Por Heuvers, Marlies E, Aerts, Joachim G, Cornelissen, Robin, Groen, Harry, Hoogsteden, Henk C, Hegmans, Joost P
Publicado em 2012

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis

Por Pedrosa, Rute M. S. M., Mustafa, Dana A. M., Aerts, Joachim G. J. V., Kros, Johan M.
Publicado no Front Oncol (2018)

Early Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018

Por Osarogiagbon, Raymond U., Veronesi, Giulia, Fang, Wentao, Ekman, Simon, Suda, Kenichi, Aerts, Joachim G., Donington, Jessica
Publicado no J Thorac Oncol (2019)

The relation between psychological profiles and quality of life in patients with lung cancer

Por van Montfort, Eveline, de Vries, Jolanda, Arts, Rita, Aerts, Joachim G., Kloover, Jeroen S., Traa, Marjan J.
Publicado no Support Care Cancer (2019)

Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinoma

Por Tan Youke KY, Liem Hauw, Antonisse Imogeen E, Senan Suresh, Cornelissen Robin, Rudolphus Arjan, Aerts Joachim GJV
Publicado em 2007-01-01

Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinoma

Por Cornelissen, Robin, Senan, Suresh, Antonisse, Imogeen E, Liem, Hauw, Tan, Youke KY, Rudolphus, Arjan, Aerts, Joachim GJV
Publicado em 2007

The association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lun...

Por de Mol, Mark, Visser, Sabine, Aerts, Joachim, Lodder, Paul, van Walree, Nico, Belderbos, Huub, den Oudsten, Brenda
Publicado no BMC Cancer (2020)

Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two c...

Por Mankor, Joanne M., Disselhorst, Maria J., Poncin, Myrthe, Baas, Paul, Aerts, Joachim G.J.V., Vroman, Heleen
Publicado no EBioMedicine (2020)